التداخل بين ألموتريبتان ودولوكسيتين
ألموتريبتان ودولوكسيتين: كلتا نشرتَي الوصف تنبّهان إلى هذا الجمع بأشد العبارات، مثل مانع استعمال أو تحذير مؤطر أو تعليمات بتجنّبه.
لا تجمع بينهما دون توجيه من الطبيب الواصف. عبارات النشرة الواردة أدناه هي أشد ما تستخدمه FDA.
ما تقوله نشرات FDA
من نشرة دولوكسيتين (Duloxetine) · تاريخ السريان 2026-03-02
Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents but also when taken alone.
If concomitant use of Duloxetine Delayed-Release Capsules with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms.
Other Serotonergic Drugs Prevention or Management Monitor for symptoms of serotonin syndrome when Duloxetine Delayed-Release Capsules is used concomitantly with other drugs that may affect the serotonergic neurotransmitter systems.
If serotonin syndrome occurs, consider discontinuation of Duloxetine Delayed-Release Capsules and/or concomitant serotonergic drugs [see Dosage and Administration ( 2.6 ), Warnings and Precautions ( 5.4 )] .
Mechanism and Clinical Effect(s) Concomitant use of Duloxetine Delayed-Release Capsules with other serotonergic drugs increases the risk of serotonin syndrome.
من نشرة ألموتريبتان (almotriptan) · تاريخ السريان 2025-12-31
Potentially life-threatening serotonin syndrome, particularly in combination with selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs).
SSRI or SNRI: life-threatening serotonin syndrome reported during combined use with triptans ( 5.5 , 7.3 )
Selective Serotonin Reuptake Inhibitors/Serotonin Norepinephrine Reuptake Inhibitors Cases of life-threatening serotonin syndrome have been reported during combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) [see Warnings and Precautions ( 5.5 ), Clinical Pharmacology ( 12.3 )] .
If concomitant treatment with almotriptan tablets and an SSRI (e.g., fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram) or SNRI (e.g., venlafaxine, duloxetine) is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases.
Serotonin Syndrome The development of a potentially life-threatening serotonin syndrome may occur with triptans, including almotriptan tablets, particularly during combined use with selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs).
هل تتناول أكثر من هذين الاثنين؟ التداخلات تتراكم. افحص قائمتك كاملة دفعة واحدة؛ وهي تبقى في متصفحك.
افتح في الفاحصليست نصيحة طبية. يقتبس Interaction Checker نص نشرات FDA وصحائف الوقائع الصادرة عن NIH. وأهمية التداخل في حالتك تتوقف على الجرعات والتوقيت ووظائف الكلى والكبد والحالات الصحية الأخرى. تأكّد من ذلك مع صيدلي أو مع الطبيب الواصف.